Episodes
-
Professor Stephen Nicholls and Professor Alberico Catapano discuss the ORION-8 phase 3 clinical trial and analyse its implications for ASCVD management and ongoing research.
-
Professor Alberico Catapano joins Professor Stephen Nicholls to discuss the SANTORINI study exploring gaps and unmet needs in ASCVD and how they impact clinical practice. Professor Catapano emphasises the pivotal role of the SANTORINI study in improving clinical practice by providing additional data to guide clinicians in LDL-C reduction in medium to high-risk individuals with ASCVD.
-
Missing episodes?
-
Listen to Professor Stephen Nicholls and Professor Kausik Ray discuss the results of the bempedoic acid cardiovascular efficacy trial, CLEAR Outcomes. Hear about the ethical considerations in this population of patients who cannot tolerate statins and why the findings are also good news for those beyond this specific subgroup.
-
Professor Oliver Weingärtner is joined by Professor Stephen Nicholls to discuss the relationship between lipoprotein(a) and the association with atherosclerotic cardiovascular disease and aortic stenosis. Take a deep dive into the European Atherosclerosis Societies Consensus Statement and what it means for patients with ASCVD.
-
Professor Kausik Ray joins Professor Stephen Nicholls to discuss the two Phase 3 clinical trials, ORION 10 and 11; studies exploring gaps and unmet needs in the management of ASCVD and how they impact clinical practice.
-
Join Professor Stephen Nicholls and Professor Kausik Ray as they discuss the implications of the DA VINCI study on patients with ASCVD across Europe. This podcast takes a deep dive into the EU-wide cross-sectional study into the use of lipid-modifying therapies used in primary and secondary care.
